Project Grant K23HL181208
- This $237,750 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Temple University aims to investigate the impact of an equity-focused implementation strategy on participation and uptake of Universal School Meals (USM) among students at highest risk for food insecurity and obesity. The project seeks to build on the principal investigator's existing K01 award, utilizing a multi-method approach to determine if the equity-focused...
- This federal Project Grant award of $708,678, provided by the National Heart, Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to conduct a Sequential Multiple Assignment Randomized Trial (SMART) to reduce food insecurity and improve adherence in patients with hypertension. The key products and services to be delivered under this grant include: Determining the most effective initial food insecurity intervention (resource information or community health worker...
- This $373,168 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the Postdoctoral Research Training in Child Health Equity program at Rhode Island Hospital, a division of Lifespan Corporation. The program aims to address persistent health inequities in pediatric conditions such as asthma, obesity, and sleep problems that disproportionately impact minoritized and socioeconomically under-resourced children. The training...
- The National Heart Lung and Blood Institute has awarded a $841,555 Cooperative Agreement under the Cardiovascular Diseases Research program (CFDA 93.837) to Harvard Pilgrim Health Care Inc. The "ENHANCE" project aims to integrate a nutrition enhancement within established, evidence-based, federally funded home visiting programs to promote healthier eating patterns and food access for families from lower incomes and underserved communities. The multi-level intervention will be...
- This $674,300 Project Grant awarded by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) examines implementation of policy changes to the National School Lunch and Breakfast Programs (NSLP/SBP). The goal is to describe the impact of NSLP/SBP policy changes, such as new flexibilities for school nutrition standards, and identify ways to improve effectiveness and equity of program implementation. The project involves a three-phase study. Phase 1 will...
- This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $777,954 to the Icahn School of Medicine at Mount Sinai to conduct research on improving preconception cardiovascular health among adolescents. The key products and services to be delivered through this grant include: Constructing a school-based adolescent preconception cohort through data linkages to study the influence of school environments on cardiovascular risk...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $1,381,876 to the University of Alaska Fairbanks to implement the "NEQPIAPUT IINRUUGUT (OUR FOOD IS MEDICINE): TESTING A TRIBALLY-DRIVEN INTERVENTION TO PREVENT HEART DISEASE AMONG ALASKA NATIVE COMMUNITIES" intervention. The 12-month, strengths-based and tribally led program aims to address disparities in coronary heart disease among Yup'ik Alaska...
- This Project Grant award, totaling $169,444, was provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to develop and pilot test a stress management intervention for Black adults with hypertension. The project will work with patients receiving care from federally-qualified health centers to iteratively design an intervention that addresses patient preferences and aims to promote cardiovascular health. Key outcomes to be examined include...
- This $798,698 project grant, awarded by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), aims to comprehensively characterize cardiac and physical function in youth with perinatally-acquired HIV (YPNHIV) compared to HIV-unexposed (HU) and HIV-exposed uninfected (PHEU) individuals. The research will utilize cardiac imaging, physical function assessment, autonomic dysfunction analysis, and molecular profiling to elucidate determinants of...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $774,229 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Kaiser Foundation Hospitals to conduct a large longitudinal cohort study on cardiometabolic outcomes among adolescents and young adults (AYA). The goal is to better understand the epidemiology of cardiometabolic conditions like hypertension, prediabetes, and fatty liver disease in AYA populations, identify high-risk groups, and inform early...
This Project Grant award of $195,696.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to co-develop the Active, Nourished, and Empowered Teens (ANET) program, a modular nutrition and fitness intervention for community youth. The project will engage a youth advisory panel to co-design the intervention, which seeks to empower adolescents in their nutrition and physical activity choices while fostering advocacy for nutritional and environmental justice. Key activities include: Defining and adapting behavior change techniques to create the ANET intervention modules, with the research team and youth panel co-designing protocols and training materials. Gathering qualitative feedback on the intervention's acceptability and feasibility through focus groups to refine the program and identify implementation barriers. Evaluating the feasibility of the ANET intervention through a 1-arm trial to obtain critical information for a future pilot randomized control trial. The project will be conducted by Rhode Island Hospital, a division of Lifespan Corporation, from September 2025 through June 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $195.7k | 9/5/25 |